<DOC>
	<DOCNO>NCT01952314</DOCNO>
	<brief_summary>This study investigate whether naftopidil effective spontaneous passage ureteral stone size 3 10 mm .</brief_summary>
	<brief_title>Medical Expulsive Therapy Ureter Stone Using Naftopidil</brief_title>
	<detailed_description>1 . Enrollment 1. patient ureteral stone size 3 10 mm 2. patient age 18 year 2 . Randomization 1. naftopidil 75 mg qd 14 day placebo 2 . Standard treatment pain-killers also apply . ( aceclofenac ) 3 . Follow-up 28 day 1 . We confirm stone free status CT X-ray film 14th 28th day . 2 . Rates active treatment also evaluate .</detailed_description>
	<mesh_term>Ureteral Calculi</mesh_term>
	<mesh_term>Ureterolithiasis</mesh_term>
	<mesh_term>Naftopidil</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>&gt; = 20 year single 3 10 mm ureter stone ( long diameter ) Presence multiple ureter stone Renal insufficiency ( serum Cr &gt; 1.4 mg/dL ) Febrile urinary tract infection ( fever &gt; 38Â°C , evidence urinary infection ) pregnancy breast feed solitary kidney hypersensitivity naftopidil current use alphablocker , calciumchannel blocker , corticosteroid ( within 4 week ) moderate severe cardiovascular cerebrovascular disease hepatic dysfunction ( &gt; 2 x normal upper limit ) significant active medical illness opinion investigator would preclude protocol treatment Genetic disorder Galactose intolerance , Lapp Lactase deficiency , GlucoseGalactose malabsorption</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>